• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    OLAPLEX Announces CFO Transition

    4/4/24 5:20:39 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $OLPX alert in real time by email

    SANTA BARBARA, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or "the Company") today announced that Eric Tiziani will step down as Chief Financial Officer to pursue another opportunity, effective May 3. The company has launched an external search for a new CFO in partnership with a leading executive search firm. While the search is underway, Paul Kosturos, a seasoned financial executive with over 30 years of experience, will join OLAPLEX and serve as Interim CFO following Mr. Tiziani's departure. Mr. Tiziani will work closely with Mr. Kosturos in the weeks ahead to facilitate a smooth transition.

    "On behalf of everyone at OLAPLEX, I want to thank Eric for his many contributions to the company," said Amanda Baldwin, Chief Executive Officer of OLAPLEX. "His strong financial acumen and his collaborative leadership helped OLAPLEX navigate through key moments of transformation – including the Company's initial public offering in 2021 – while achieving top-tier industry profitability. We wish Eric all the best."

    Ms. Baldwin continued, "We are fortunate to have Mr. Kosturos' extensive experience in the retail and consumer industries while we search for a permanent successor. I look forward to working closely with Paul and our excellent team to continue executing a strategy that builds on our strong business model to return to consistent sales and profit growth."

    Mr. Tiziani said, "It has been a privilege to be part of OLAPLEX's journey and work alongside such talented individuals. OLAPLEX has an extraordinary foundation, and I am confident in Amanda's leadership and the progress the business is making to realize its tremendous potential. I am excited to see its many future successes."

    Mr. Kosturos is a Managing Director at Alvarez & Marsal, where he has specialized in interim CFO assignments since 2009, and has worked in a variety of industries, including retail, consumer goods, restaurants, manufacturing, software solutions and telecommunications.

    In addition to announcing the CFO transition, the Company today reaffirmed its previously disclosed guidance for net sales for the first quarter of 2024 in the range of $92 million to $97 million, as provided in the Company's press release issued on February 29, 2024.

    The Company's actual net sales results for the first quarter of 2024 are subject to completion of the Company's quarter-end closing procedures.

    About OLAPLEX

    OLAPLEX is an innovative, science-enabled, technology-driven beauty company with a mission to improve the hair health of its consumers. In 2014, OLAPLEX disrupted and revolutionized the prestige hair care category by creating innovative bond-building technology, which works by protecting, strengthening and relinking broken bonds in the hair during and after hair services. The brand's proprietary, patent-protected ingredient works on a molecular level to protect and repair damaged hair. OLAPLEX's award-winning products are sold through an expanding omnichannel model serving the professional, specialty retail and direct-to-consumer channels.

    Cautionary Note Regarding Forward Looking Statements

    This press release includes certain forward-looking statements and information relating to the Company that are based on the beliefs of management as well as assumptions made by, and information currently available to, the Company. These forward-looking statements include, but are not limited to, statements about: the Company's chief financial officer transition and search for a permanent chief financial officer; the Company's financial position and operating results, including its net sales guidance for the first quarter of 2024; the Company's strategy and business model; and other statements contained in this press release that are not historical or current facts. When used in this press release, words such as "may," "will," "could," "should," "intend," "potential," "continue," "anticipate," "believe," "estimate," "expect," "plan," "target," "predict," "project," "forecast," "seek" and similar expressions as they relate to the Company are intended to identify forward-looking statements.

    The forward-looking statements in this press release reflect the Company's current expectations and projections about future events and financial trends that management believes may affect the Company's business, financial condition and results of operations. These statements are predictions based upon assumptions that may not prove to be accurate, and they are not guarantees of future performance. In addition, the Company's actual net sales results for the first quarter of 2024 are subject to completion of the Company's quarter-end closing procedures. As such, you should not place significant reliance on this guidance or on the Company's other forward-looking statements. Neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements, including any such statements taken from third party industry and market reports.

    Forward-looking statements involve known and unknown risks, inherent uncertainties and other factors that are difficult to predict which may cause the Company's actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements, including, without limitation: the risk that the Company cannot identify and recruit a permanent chief financial officer in a timely manner; competition in the beauty industry; the Company's ability to effectively maintain and promote a positive brand image, expand its brand awareness and maintain consumer confidence in the quality, safety and efficacy of its products; the Company's ability to anticipate and respond to market trends and changes in consumer preferences and execute on its growth strategies and expansion opportunities, including with respect to new product introductions; the Company's ability to accurately forecast customer and consumer demand for its products; the Company's dependence on the success of its long-term strategic plan; the Company's ability to limit the illegal distribution and sale by third parties of counterfeit versions of its products or the unauthorized diversion by third parties of its products; the Company's dependence on a limited number of customers for a large portion of its net sales; the Company's ability to develop, manufacture and effectively and profitably market and sell future products; the Company's ability to attract new customers and consumers and encourage consumer spending across its product portfolio; the Company's ability to successfully implement new or additional marketing efforts; the Company's relationships with and the performance of its suppliers, manufacturers, distributors and retailers and the Company's ability to manage its supply chain; impacts on the Company's business from political, regulatory, economic, trade and other risks associated with operating internationally; the Company's ability to manage its executive leadership change and to attract and retain senior management and other qualified personnel; the Company's reliance on its and its third-party service providers' information technology; the Company's ability to maintain the security of confidential information; the Company's ability to establish and maintain intellectual property protection for its products, as well as the Company's ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the outcome of litigation and regulatory proceedings; the impact of changes in federal, state and international laws, regulations and administrative policy; the Company's existing and any future indebtedness, including the Company's ability to comply with affirmative and negative covenants under its credit agreement; the Company's ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; volatility of the Company's stock price; the Company's "controlled company" status and the influence of investment funds affiliated with Advent International, L.P. over the Company; the impact of an economic downturn and inflationary pressures on the Company's business; fluctuations in the Company's quarterly results of operations; changes in the Company's tax rates and the Company's exposure to tax liability; and the other factors identified under the heading "Risk Factors" in Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") and in the other documents that the Company files with the SEC from time to time.

    Many of these factors are macroeconomic in nature and are, therefore, beyond the Company's control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in this press release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements in this press release represent management's views as of the date hereof. Unless required by law, the Company neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date hereof to conform these statements to actual results or to changes in the Company's expectations or otherwise.

    Contacts

    For Investors:

    Patrick Flaherty

    Vice President, Investor Relations

    [email protected] 

    For Media:

    Lisa Bobroff

    Vice President, Global Communications & Consumer Engagement

    [email protected] 

     



    Primary Logo

    Get the next $OLPX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OLPX

    DatePrice TargetRatingAnalyst
    1/14/2026$1.50Hold
    Jefferies
    11/20/2025$2.00Outperform
    Northland Capital
    8/25/2025$2.00Hold → Buy
    Canaccord Genuity
    8/7/2024$2.00 → $3.00Market Perform
    Telsey Advisory Group
    3/19/2024$1.25 → $2.00Underweight → Neutral
    Piper Sandler
    10/4/2023Underweight → Equal Weight
    Barclays
    8/25/2023$3.00 → $2.00Neutral → Underweight
    Piper Sandler
    8/11/2023$5.00 → $3.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $OLPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Baldwin Amanda sold $474,286 worth of shares (398,560 units at $1.19), decreasing direct ownership by 6% to 5,735,198 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    12/15/25 4:08:33 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Glynn Tricia was granted 110,294 shares, increasing direct ownership by 80% to 248,693 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    8/15/25 9:42:25 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director White Michael James was granted 110,294 shares, increasing direct ownership by 80% to 248,693 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    8/15/25 9:41:18 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Egan Kenneth F bought $13,400 worth of shares (10,000 units at $1.34) (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    3/18/25 4:03:21 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Bilbrey John P bought $134,695 worth of shares (76,825 units at $1.75) (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    11/19/24 4:04:17 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Chief Executive Officer Baldwin Amanda bought $74,390 worth of shares (43,000 units at $1.73), increasing direct ownership by 1% to 3,205,055 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    11/12/24 4:19:40 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Olaplex Holdings, Inc. to Report Third Quarter Fiscal 2025 Financial Results on November 6th

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report third quarter fiscal 2025 financial results before the market opens on Thursday, November 6, 2025. The company plans to host an investor conference call and webcast to review third quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakt

    10/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings, Inc. Announces Participation in the Barclays 18th Annual Global Consumer Staples Conference on September 2nd

    NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced its participation in the Barclays 18th Annual Global Consumer Staples Conference in Boston, MA. Amanda Baldwin, Chief Executive Officer, and Catherine Dunleavy, Chief Operating Officer & Chief Financial Officer, will present on Tuesday, September 2, 2025 at 3:45pm ET and hold meetings with investors throughout the day. The audio portion of the fireside chat will be available on the Company's Investor Relations website, https://ir.olaplex.com/, and will remain there for 90 days following the event. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakthrough innovat

    8/27/25 4:05:00 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Acquires Biotech Company Purvala

    NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare. Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules i

    8/26/25 6:55:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    SEC Filings

    View All

    SEC Form 10-Q filed by Olaplex Holdings Inc.

    10-Q - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    11/6/25 4:03:24 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    11/6/25 6:46:53 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    8/26/25 6:55:13 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Olaplex with a new price target

    Jefferies resumed coverage of Olaplex with a rating of Hold and set a new price target of $1.50

    1/14/26 8:43:59 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Northland Capital initiated coverage on Olaplex with a new price target

    Northland Capital initiated coverage of Olaplex with a rating of Outperform and set a new price target of $2.00

    11/20/25 9:42:07 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Olaplex from Hold to Buy and set a new price target of $2.00

    8/25/25 8:08:37 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Leadership Updates

    Live Leadership Updates

    View All

    OLAPLEX Expands Board of Directors with Strategic Appointments

    NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") appointed Jerome Griffith to the Company's Board of Directors (the "Board"), effective July 20, 2025, joining Pamela Edwards, who was appointed to the Board effective March 20, 2025. Ms. Edwards is a highly experienced financial leader, having served as a Chief Financial Officer for several large specialty retailers and consumer brands. Most recently, Ms. Edwards served as the Chief Financial Officer and Executive Vice President of Citi Trends, Inc., a publicly held, leading specialty value store with a rich history of bringing fashionable products across categories from fashion a

    7/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Strengthens Senior Leadership Team with Key Appointments

    NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or "the Company") today announced the appointment of two highly seasoned leaders to its executive team. Catherine Dunleavy will join OLAPLEX as Chief Operating Officer and Chief Financial Officer, effective August 13, and Katie Gohman will join the Company as Chief Marketing Officer, effective July 15. Ms. Dunleavy brings more than two decades of experience driving the strategy and performance of premier consumer brands. Most recently, she served as President, and, prior to that, as Chief Financial Officer at Away, following tenures at Nike, Comcast, NBCUniversal, and GE. In her new role, she will

    7/11/24 8:00:40 AM ET
    $OLPX
    $TGNA
    Package Goods/Cosmetics
    Consumer Discretionary
    Broadcasting
    Industrials

    OLAPLEX Appoints Global Consumer Industry Veteran John P. Bilbrey to Board of Directors

    SANTA BARBARA, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company"), today announced that it has appointed John P. "JP" Bilbrey to the Company's Board of Directors (the "Board"). A seasoned and accomplished executive within the global consumer space, Mr. Bilbrey will serve in the newly created role of Executive Chair of the Board. Christine Dagousset, who has been a board member of the Company and its predecessor entities since May 2020 and has served as Chair of the Board since August 2021, will continue to serve as a valued director and will transition from a member of the Compensation Committee to a member of the Nominating and Corp

    7/11/23 8:00:47 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Financials

    Live finance-specific insights

    View All

    Olaplex Holdings, Inc. to Report Third Quarter Fiscal 2025 Financial Results on November 6th

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report third quarter fiscal 2025 financial results before the market opens on Thursday, November 6, 2025. The company plans to host an investor conference call and webcast to review third quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakt

    10/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Acquires Biotech Company Purvala

    NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare. Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules i

    8/26/25 6:55:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings, Inc. to Report Second Quarter Fiscal 2025 Financial Results on August 7th

    NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report second quarter fiscal 2025 financial results before the market opens on Thursday, August 7, 2025. The company plans to host an investor conference call and webcast to review second quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by br

    7/24/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Olaplex Holdings Inc. (Amendment)

    SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/14/24 4:00:32 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Olaplex Holdings Inc. (Amendment)

    SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/9/24 9:28:33 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G filed by Olaplex Holdings Inc.

    SC 13G - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/9/23 12:01:00 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary